Continued Growth Hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 10, 2004, Pages 4857-4862

  Attanasio, Andrea F ^g   Shavrikova, Elena ^b   Blum, Werner F ^f   Cromer, Morris ^c   Child, Christopher J ^c   Paskova, Magdalena ^d   Lebl, Jan ^e   Chipman, John J ^c   Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b PSI   (Russian Federation)

^c ELI LILLY AND COMPANY   (United States)

^d Children's Hospital   (Slovakia)

^e CHARLES UNIVERSITY   (Czech Republic)

^f LILLY DEUTSCHLAND GMBH   (Germany)

^g Lilly Research   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BODY HEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; TREATMENT FAILURE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGE OF ONSET; BODY COMPOSITION; BODY HEIGHT; BODY MASS INDEX; CHOLESTEROL; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROSPECTIVE STUDIES;

EID: 6344241114     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0551     Document Type: Article

References (24)

1. Guyda HJ 1999 Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84:4307-4316
2. Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A 1996 Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Horm Res 48:62-71
3. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF, Shalet SM 2002 Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 87:3368-3372
4. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP 1992 Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 75:1060-1065
5. Forbes GB 1972 Relation of lean body mass to height in children and adolescents. Pediatr Res 6:32-37
6. Barlett HL, Puhl SM, Hodgson JL, Buskirk ER 1991 Fat-free mass in relation to stature: ratios of fat-free mass to height in children, adults, and elderly subjects. Am J Clin Nutr 53:1112-1116
7. Forbes GB 1981 Body composition in adolescence. Prog Clin Biol Res 61:55-72
8. Fors H, Bjarnason R, Wirén L, Albertsson-Wikland K, Bosaeus I, Bengtsson B-Å, Johannsson G 2001 Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents. Clin Endocrinol (Oxf) 55: 617-624
9. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hübner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP 2003 The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 88:1658-1663
10. Rutherford OM, Jones DA, Round JM, Preece MA 1991 Changes in skeletal muscle after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol (Oxf) 34:469-475
11. Johansson G, Albertsson-Wikland K, Swedish Study Group for Growth Hormone Treatment in Children, Bengtsson B-Å 1999 Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH sufficient adolescent patients compared with control subjects. J Clin Endocrinol Metab 84:4516-4524
12. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalova J, Moshang TA, Blum WF, Chipman JJ, Quigley C, Attanasio AF 2003 Effect of growth hormone (GH) treatment on bone in post-pubertal GH deficient (GHD) patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab 88:4124-4129
13. Prader A, Largo RH, Molinari C, Issler C 1989 Physical growth of Swiss children from birth to 20 yr of age. Helv Paediatr Acta 52(Suppl):1-125
14. Vahl N, Juul A, Jørgensen JOL, Ørskov H, Skakkebaek NE, Christiansen JS 2000 Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo controlled study. J Clin Endocrinol Metab 85:1874-1881
15. Underwood LE, Attie KM, Baptista J; the Genentech Collaborative Study Group 2003 Growth hormone (GH) dose-response in young adults with childhood onset GH deficiency: a two-year, multicenter, multiple-dose, placebo controlled study. J Clin Endocrinol Metab 88:5273-5280
16. Koranyi, Svensson J, Gotherstrom G, Sunnerhagen KS, Bengtsson B-Å, Johansson G 2001 Baseline characteristics and the effect of five years of GH replacement therapy in adults with GH deficiency of childhood or adult onset: a comparative, prospective study. J Clin Endocrinol Metab 86:4693-4699
17. Götherström G, Svensson J, Koranyi M, Bosaeus I, Bengtsson B-Å, Johansson G 2001 A prospective study of 5 years GH replacement in GH deficient adults: sustained effects on body composition, bone mass, and metabolic indices. J Clin Endocrinol Metab 86:4657-4665
18. Attanasio AF, Lamberts SWJ, Matranga AMC, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ 1997 Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab 82:82-88
19. Janssen YJ, Frolich M, Roelfsma F 1997 A low starting dose of genotropin in growth hormone deficient adults. J Clin Endocrinol Metab 82:129-135
20. Lissett CA, Murray RD, Shalet SM 2002 Timing of onset of growth hormone deficiency is a major influence on insulin-like growth factor status in adult life. Clin Endocrinol (Oxf) 57:35-40
21. Beshyah SA, Anyaoku V, Newton P, Johnston DG 1994 Metabolic abnormalities in growth hormone deficient adults. I. Serum insulin like growth factor-1. Endocrinol Metab 1:167-172
22. Lissett CA, Jönsson P, Monson JP, Shalet SM 2003 Determinants of IGF-I status in a large cohort of growth hormone-deficient (GHD) subjects: the role of timing of GHD. Clin Endocrinol (Oxf) 59:773-778
23. Weissberger AJ, Ho KY, Lazarus L 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I and GH binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381
24. Cook DM, Ludlam WH, Cook MB 1999 Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH deficient adults. J Clin Endocrinol Metab 84:3956-3960